Our data show that as compared to non-growth factor treatments, the therapeutic use of growth factor products including FGF, EGF and GM-CSF for acute wounds significantly changed the healing outcome in terms of lessening healing time, heightening healing rate and reducing incidence of infections and adverse reactions. Here, EGF is linked to infection.